Regardless, we observed a high co-occurrence of MC1R variants and high MITF expression in melanoma patients (up to 38% co-occurrence), indicating that a subset of melanoma may be driven by mechanisms similar to those reported for the model presented here. The gene discussed is MITF; the disease is melanoma.